DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / HEALTHCARE BUL
Symbol
CURE
Price per share
$111.57
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
160,603
Total reported value
$13,403,499
% of total 13F portfolios
0%
Share change
+72,208
Value change
+$6,201,049
Number of holders
22
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 22 institutional investors reported holding 160,603 shares of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE).

Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,222 $582,609 -$60,358 $111.57 1
2025 Q3 160,603 $13,403,499 +$6,201,049 $83.52 22
2025 Q2 104,829 $8,738,642 -$2,121,035 $78.82 21
2025 Q1 119,630 $12,749,419 -$3,651,625 $106.61 21
2024 Q4 162,215 $14,967,674 +$2,061,776 $92.29 23
2024 Q3 117,641 $14,975,249 -$10,934,695 $133.18 20
2024 Q2 209,029 $24,832,086 -$619,320 $116.81 21
2024 Q1 212,892 $26,661,184 +$106,676 $125.45 23
2023 Q4 212,898 $21,651,140 +$391,279 $101.74 21
2023 Q3 211,193 $18,695,500 +$3,183,011 $88.53 20
2023 Q2 172,863 $17,292,257 +$3,960,921 $100.01 20
2023 Q1 111,129 $10,668,334 +$5,851,533 $96.00 13
2022 Q4 48,370 $5,550,191 -$3,270,942 $114.76 20
2022 Q3 75,620 $6,384,394 +$4,299,090 $84.44 18
2022 Q2 24,736 $2,549,132 -$6,735,919 $103.08 17
2022 Q1 82,130 $10,714,439 -$2,026,082 $130.45 22
2021 Q4 93,191 $13,512,085 +$5,665,141 $144.98 20
2021 Q3 59,622 $6,415,296 +$3,553,189 $107.43 19
2021 Q2 26,189 $2,785,000 -$1,481,857 $104.58 14
2021 Q1 90,189 $7,533,644 -$4,130,827 $83.51 15
2020 Q4 144,746 $11,147,104 +$4,022,795 $77.00 17
2020 Q3 92,309 $5,870,731 -$7,543,034 $63.02 13
2020 Q2 215,776 $11,724,759 +$1,931,785 $54.33 15
2020 Q1 180,011 $7,164,157 -$2,162,961 $39.83 13
2019 Q4 235,161 $17,326,593 +$171,216 $73.68 16
2019 Q3 234,450 $11,856 -$5,214 $0.05 17
2019 Q2 328,279 $18,426 -$314 $0.06 16
2019 Q1 262,640 $14,599,783 +$3,499,448 $55.58 12
2018 Q4 199,383 $9,488,000 +$2,674,821 $47.59 13
2018 Q3 141,882 $9,454,545 -$4,469,599 $66.63 13
2018 Q2 248,899 $11,283,000 +$3,462,492 $45.37 18
2018 Q1 173,165 $7,453,000 +$2,373,455 $43.05 16
2017 Q4 116,193 $5,414,000 -$3,613,483 $46.60 14
2017 Q3 193,068 $8,762,000 -$1,412,493 $45.48 9
2017 Q2 238,248 $9,943,260 +$1,840,958 $41.71 13
2017 Q1 181,464 $6,253,820 -$1,133,089 $34.45 13
2016 Q4 239,800 $6,613,000 -$232,500 $27.57 14
2016 Q3 $31.03 1
2016 Q2 0 $0 -$167,840 $30.74 1
2016 Q1 159,786 $4,337,840 -$1,605,157 $27.15 12
2015 Q4 211,884 $7,076,400 +$2,802,828 $33.40 12
2015 Q3 127,415 $3,369,280 -$6,207,309 $26.44 10
2015 Q2 262,705 $10,329,920 +$6,738,740 $39.32 11
2015 Q1 69,646 $10,242,669 -$2,877,026 $147.08 13
2014 Q4 96,637 $12,023,156 +$8,809,291 $124.43 14
2014 Q3 23,762 $2,454,980 -$6,256,051 $103.29 7
2014 Q2 94,498 $8,468,740 +$1,164,730 $89.62 9
2014 Q1 83,752 $6,714,255 +$2,631,708 $80.16 6